IL6 and COVID-19: For example, Liu and colleagues reported a 67.9% increase in IL-6 in patients with COVID-19 and found that levels of IL-6 and C-reactive protein (CRP, a biomarker of inflammation) in the severe group was significantly higher than in the mild group [107].